-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – IONIS-PKKRx in Migraine
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.IONIS-PKKRx in MigraineDrug Details:IONIS-PKKRx is under development for treatment of hereditary angioedema and chronic migraine. It...
-
Product Insights
![]()
PG&E Corp – The Nighthawk Storage 300 MW Project – California
Equip yourself with the essential tools needed to make informed and profitable decisions with our PG&E Corp - The Nighthawk Storage 300 MW Project - California report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Azenosertib in Fallopian Tube Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Azenosertib in Fallopian Tube Cancer Drug Details: Azenosertib (ZNC-3) is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Isatuximab in T-Cell Lymphomas
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Isatuximab in T-Cell Lymphomas Drug Details: Isatuximab (Sarclisa) is a monoclonal antibody acts as anticancer...
-
Company Profile
![]()
NightHawk Biosciences Inc – Company Profile
NightHawk Biosciences Inc (NightHawk Biosciences) formerly Heat Biologics Inc, is a leading biotechnology company specializing in the development and commercialization of advanced medical technologies and therapies. Its major commercially available product is Anthim (obiltoxaximab), an FDA-approved monoclonal antibody specifically developed for the treatment of inhalational anthrax. Anthim has received orphan drug exclusivity, highlighting its unique status in addressing this serious medical condition. It is also approved in Europe, Canada and the UK. NightHawk Biosciences is headquartered in Durham, North Carolina,...
Add to Basket -
Company Profile
![]()
NETGEAR Inc – Company Profile
NETGEAR Inc (Netgear) develops premium networking devices that are cutting-edge, high-performing, and link people, businesses, and service providers. The company’s product portfolio comprises ethernet switches, wireless controllers, digital canvas, modems, routers, gateways, and network storage products. It also offers whole-home networking hardware and software solutions and 4G LTE hotspots. Netgear markets its products under NPG, AirCard, Around Town, Orbi, Genie, ReadyShare, NETGEAR, ProSafe, RangeMax, Streampro, Centria, MyMedia, and Nighthawk brand names. It sells products through traditional retailers, online retailers, wholesale...
Add to Basket -
Product Insights
![]()
Zika Virus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Zika Virus Infections Pipeline Drugs Market Report Overview Zika virus infection is caused by a virus transmitted primarily by Aedes mosquitoes. Symptoms include fever, skin rashes, conjunctivitis, muscle and joint pain, malaise, and headache. Risk factors include being in tropical and subtropical areas. Zika virus can be transmitted through sexual intercourse. Treatment is aimed at relieving symptoms (joint pain and fever) with fluids and medications. The Zika Virus Infections pipeline drugs market research report provides comprehensive information on the Zika...
-
Product Insights
![]()
Non-Small Cell Lung Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Non-Small Cell Lung Cancer Pipeline Drugs Market Report Overview Non-small cell lung cancer (NSCLC) is the most common type of lung cancer. NSCLC is a cancer (malignancy) that originates in the tissues of the lungs or the cells lining the airways. Symptoms of lung cancer usually occur in the later stages of the disease. The signs and symptoms include a persistent cough that may get worse over time, trouble breathing or shortness of breath, constant chest pain or discomfort, bloody...
-
Product Insights
![]()
Net Present Value Model: Viagenpumatucel-L
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Viagenpumatucel-L Drug Details Viagenpumatucel-L (HS-110) is...
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – HS-130
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry HS-130 Drug Details HS-130 is under development for the treatment of non-small cell lung...
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – PTX-35
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry PTX-35 Drug Details PTX-35 is under development for the treatment of melanoma, multiple solid...
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – viagenpumatucel-L
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry viagenpumatucel-L Drug Details Viagenpumatucel-L (HS-110) is under development for the treatment of solid tumors...
-
Product Insights
![]()
Melanoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Melanomas usually occur on the skin but can arise in other locations where neural crest cells migrate, such as in the gastrointestinal tract or brain. It is more common in women than in men. The Melanoma pipeline market research report provides comprehensive information on the therapeutics under development for Melanoma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the...
-
Product Insights
![]()
Type 1 Diabetes (Juvenile Diabetes) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Type 1 Diabetes Pipeline Drugs Market Report Overview Type 1 diabetes (T1D) occurs when the body’s immune system attacks and destroys the insulin-producing cells in the pancreas. The signs and symptoms of type 1 diabetes include increased thirst and frequent urination, extreme hunger, weight loss, fatigue, and irritability or unusual behavior. The Type 1 Diabetes pipeline drugs market research report provides comprehensive information on the therapeutics under development for Type 1 Diabetes (Juvenile Diabetes) (Metabolic Disorders), complete with analysis by...
-
Product Insights
![]()
Asthma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Asthma, a chronic disease involving the airways in the lungs, may occur with symptoms that include shortness of breath, chest tightness or pain, chronic coughing and trouble sleeping due to coughing or wheezing. The Asthma pipeline drugs market research report outlays comprehensive information on the Asthma targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type, that are being developed by companies/universities. It also reviews key players involved in...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.